Skip to main content
PreveCeutical Medical logo

PreveCeutical Medical — Investor Relations & Filings

Ticker · PREV ISIN · CA74143C1068 LEI · 96760001OJCSH5MXZ450 CSE Professional, scientific and technical activities
Open in API
Filings indexed 438 across all filing types
Latest filing 2024-06-06 Legal Proceedings Report
Country CA Canada
Listing CSE PREV

About PreveCeutical Medical

https://www.preveceutical.com/

PreveCeutical Medical Inc. is a health sciences company dedicated to the research and development of innovative options for preventive and curative therapies. The company specializes in utilizing organic and nature identical products, combining scientific rigor with natural sources to benefit health-conscious consumers. Its primary focus is on the preventive health sector, collaborating with partners to bring novel solutions to market.

Recent filings

Filing Released Lang Actions
News release - English.pdf
Legal Proceedings Report Classification · 100% confidence The document is a press release announcing that PreveCeutical Medical Inc. has commenced litigation against its former legal counsel alleging professional negligence. It details the filing of a Notice of Civil Claim in the British Columbia Supreme Court and describes the nature of the claim and potential damages sought. There is no financial data, no discussion of financial results, no regulatory compliance filings, no voting results, no management or board changes, no capital or financing updates, and no mention of any report being attached or published. The content is focused on legal proceedings and litigation updates. Therefore, the document fits best under the category of Legal Proceedings Report (LTR).
2024-06-06 English
Report of exempt distribution (45-106F1).pdf
Regulatory Filings
2024-05-31 English
News release - English.pdf
Regulatory Filings
2024-05-30 English
News release - English.pdf
Regulatory Filings
2024-05-30 English
News release - English.pdf
Regulatory Filings Classification · 95% confidence The document is a press release from PreveCeutical Medical Inc. providing an update on a Management Cease Trade Order (MCTO) issued by the British Columbia Securities Commission due to the company's delay in filing its audited annual financial statements and related management discussion and analysis for the fiscal year ended December 31, 2023. The document discusses the reasons for the delay, the expected filing date, compliance with regulatory guidelines during the default period, and plans for a private placement to raise funds. It does not contain the actual annual report, audited financial statements, or detailed financial data. Instead, it is an update on regulatory compliance status and future filing intentions. The document is longer than 5,000 characters but is clearly an announcement/update rather than the report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance updates that do not fit other categories.
2024-05-17 English
News release - English.pdf
Regulatory Filings Classification · 100% confidence The document is a news release dated May 2, 2024, announcing that PreveCeutical Medical Inc. has missed the filing deadline for its audited annual financial statements and related management discussion and analysis for the fiscal year ended December 31, 2023. It states the company applied for a Management Cease Trade Order (MCTO) due to this delay and provides details about the MCTO and the company's plans to file the Annual Filings by June 28, 2024. The document does not contain the actual annual report or financial statements but is an announcement about the failure to file and the regulatory consequences. It also mentions a proposed private placement but does not provide details or financial data about it. The document is essentially a regulatory announcement about the company's filing default and related management cease trade order, not the annual report itself or any financial statements. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for such regulatory announcements and compliance-related disclosures that do not contain the actual report or financial data.
2024-05-03 English

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.